“…During the early stages of the disease, the patient’s leukocyte count, lymphocyte counts, total protein, serum amylase level, urine amylase level, etc, may be outside of the normal range. [13] The development of the disease leads to changes in multiple indicators and activates multiple tissues and signaling pathways, such as acinar cell death, activation of inflammatory cascades, endoplasmic reticulum (ER) stress, autophagy, and mitochondrial dysfunction in acinar cells. [14] However, the mechanisms underlying AP development remain unclear, considering only a few therapeutic approaches can significantly decrease the mortality rate of AP patients in the clinical setting.…”